Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arovella Therapeutics Ltd
Research & Development Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Research & Development
-AU$6.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Research & Development
-AU$20.2m
CAGR 3-Years
-2%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Research & Development
-AU$33.6m
CAGR 3-Years
-49%
CAGR 5-Years
-26%
CAGR 10-Years
-14%
Botanix Pharmaceuticals Ltd
ASX:BOT
Research & Development
-AU$1.8m
CAGR 3-Years
35%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vita Life Sciences Ltd
ASX:VLS
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Arovella Therapeutics Ltd's Research & Development?
Research & Development
-6.7m AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Research & Development amounts to -6.7m AUD.

What is Arovella Therapeutics Ltd's Research & Development growth rate?
Research & Development CAGR 1Y
-69%

Over the last year, the Research & Development growth was -69%.

Back to Top